In addition, the use of a panel of laboratory tests for inflammation,hypercoagulability, and organ damage (e.g., CRP, ferritin, D-dimer, cardiac enzymes,liver enzymes, and creatinine) might assist in the early identification andmanagement of this COVID-19–associated condition. This evidence concerns the gene CRP and COVID-19.